Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-07-15
著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OHNO Ryuzo
Aichi Cancer Center
-
NAGAI Tadashi
Division of Hematology, Jichi Medical University
-
永井 正
自治医科大学内科学講座血液学部門
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
永井 正
自治医科大学 内科学講座血液学部門
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Nakagawa Shun-ichi
鈴鹿中央総合病院(厚生連)
-
Komatsu H
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
三木 義男
東京医歯大 難治疾患研 疾患医科学研究系分子遺伝分野
-
Naoe Tomoki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsuboi Naoya
Cardiovascular Center Nagoya Daini Red Cross Hospital
-
Tsuboi Naoya
Division Of Cardiology Nagoya Daini Red Cross Hospital
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
USUI Noriko
Jikei University School of Medicine
-
NAOE Tomoki
Nagoya University
-
MOTOJI Toshiko
Tokyo Women's Medical University
-
MIYAZAKI Yasushi
Nagasaki University
-
OHNISHI Kazunori
Hamamatsu University School of Medicine
-
Okada Masaya
Division Of Hematology And Oncology Department Of Internal Medicine Hyogo College Of Medicine
-
Okada Masaya
兵庫医科大学 総合内科
-
Okada Masaya
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Uoshima Nobuhiko
京都府立医科大学 血液･腫瘍内科学
-
Uoshima Nobuhiko
Matsushita Memorial Hospital Moriguchi Jpn
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Taniwaki Masafumi
国立がんセンター中央病院 血液内科
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Naoe Tomoki
名古屋大学 医学系研究科血液･腫瘍内科学
-
Naoe Tomoki
大垣市民病院 血液内科
-
Nagai Tadashi
東京慈恵会医科大学 内科学講座血液内科
-
Nagai Tadashi
Division Of Hematology Department Of Medicine Jichi Medical University
-
Nagai Tadashi
Division Of Hematology Jichi Medical University
-
Tsuchida Masahiro
産業医科大学 小児科学
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Tsukamoto Norifumi
Gunma University Hospital
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
TAKEUCHI Jin
Nihon University Itabashi Hospital
-
DOBASHI Nobuaki
Jikei University Hospital
-
KANAKURA Yuzuru
Osaka University Hospital
-
TANIGUCHI Shuichi
Toranomon Hospital
-
EZAKI Koji
Fujita Health University Hospital
-
NAKASEKO Chiaki
Chiba University Hospital
-
HIRAOKA Akira
Osaka Medical Center for Cancer and Cardiovascular Diseases
-
OKADA Masaya
The Hospital of Hyogo College of Medicine
-
HIGASHIHARA Masaaki
Kitasato University Hospital
-
KIYOI Hitoshi
Nagoya University Hospital
-
NAKAO Shinji
Kanazawa University Hospital
-
SHINAGAWA Katsuji
Okayama University Hospital
-
Kiyoi Hitoshi
豊橋市民病院 血液･腫瘍内科
-
Kosugi H
Department Of Hematology Ogaki Municipal Hospital
-
Kiyoi Hitoshi
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Minami H
Department Of Hematology Fujita Health University School Of Medicine
-
Higashihara Masaaki
あけぼの病院 内科
-
Higashihara Masaaki
北里大学 医学部第4内科(血液内科)
-
Dobashi Nobuaki
東京慈恵会医科大学 内科学(血液･腫瘍)
-
Takeuchi Jin
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Hiraoka A
Fifth Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Hiraoka Akira
Department Of Hematology And Oncology Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Hiraoka Akira
Fifth Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Usui N
Jikei University Hospital
-
Tomonaga Masao
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Tanaka J
Stem Cell Transplantation Center Hokkaido University Hospital
-
Taniwaki M
Celgene Kk
-
Tanimoto Mitsune
名古屋大学 第1内科
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Naoe T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Okayama Kenichi
Department Of Internal Medicine Iii Hamamatsu University School Of Medicine
-
Odagiri Keiichi
浜松医科大学 救急医学
-
Odagiri Keiichi
Department Of Medicine Hamamatsu Red Cross Hospital
-
Matsuno Y
Department Of Surgical Pathology Hokkaido University Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Okada Masaya
Hyogo Coll. Medicine Nishinomiya Jpn
-
Sahara Naohi
浜松医科大学 内科学第3
-
Nakamura Satoki
県西部浜松医療センター 血液科
-
Shirafuji Naoki
Department Of Hematology Kanazawa University
-
Nakamura Shigeo
Department Of Pathology Nagoya University Graduate School Of Medicine
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Ohshima Koichi
First Department Of Pathology Fukuoka University
-
Ohshima Koichi
First Department Of Pathology Fukuoka University School Of Medicine
-
Ohnishi Kazunori
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center Central Hospital
-
Minami Hironobu
Oncology/hematology National Cancer Center Hospital East
-
MITSUI Yoko
Department of Surgery
-
Tomonaga Masao
Hematology Atomic Disease Institute Nagasaki University School Of Medicine
-
Matsuo Yuji
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Hirano Masami
Department Of Hematology Fujita Health University School Of Medicine
-
岡田 昌也
兵庫医科大学病院血液内科
-
Kosugi Hiroshi
Institute For Chemical Research Tohoku University
-
Nakao Shinji
Third Department Of Medicine Kanazawa University
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Dobashi Nobuaki
Jikei Univ. Hospital Tokyo Jpn
-
Morishita Yoshihisa
Department Of Hematology And Oncology Ja Aichi Showa Hospital
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Ohnishi Kazunori
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Moriuchi Yukiyoshi
Nagasaki Cml Study Group Nagasaki Jpn
-
Morishita Yasuyuki
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Hirano Masami
Kitasato University Hospital
-
Motoji Toshiko
Tokyo Women's Medical University
-
Miyazaki Yoshitsugu
The Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Hiraoka Akira
Department Of Hematology/oncology Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Nakamura S
Department Of Anatomic And Molecular Pathology Aichi Cancer Center Hospital
-
Takeuchi Jin
Department Of Internal Medicine Nihon University School Of Medicine
-
Mori Takehiko
Keio Univ. School Of Medicine Tokyo Jpn
-
Ohnishi Kazunori
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Tadashi Nagai
Division Of Hematology Department Of Medicine Jichi Medical University
-
Ohhashi Kyoichi
Department Of Clinical Pharmacology And Therapeutics Hamamatsu University School Of Medicine
-
Taguchi Jun
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Taguchi Jun
Department Of Hematology Kanagawa Cancer Center
-
Miki Yoshio
Department Of Human Genome Analysis Cancer Chemotherapy Center Japanese Foundation For Cancer Resear
-
Motoji T
Department Of Hematology Tokyo Women's Medical University
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Naruse T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Odagiri Keiichi
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Kanakura Yuzuru
Osaka University Graduate School Of Medicine
-
Ohnishi Kazunori
The Division Of Hematology Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Ohashi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
Cancer Center Hamamatsu University School Of Medicine
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Nakamura Satoko
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Takabayashi Maki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Ohnishi Kazunori
Shikoku National Hospital Matsuyama Jpn
-
Kanakura Yuzuru
Osaka Univ. Hospital Suita Jpn
-
Ohmachi Ken
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Nakamura Shigeo
Department Of Pathology Nagoya University
-
Nagai Tadashi
Division of Cell Therapy, Jichi Medical University Hospital, Shimotsuke
関連論文
- 白血病 (特集 分子標的薬治療--癌から他疾患までの治癒をめざして) -- (疾患別分子標的薬治療の現状と今後の展望 悪性腫瘍)
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- IL-21受容体細胞外ドメインを用いた移植片対宿主病治療の可能性(平成18年度自治医科大学医学部研究奨励金研究成果報告)
- 骨髄非破壊的同種骨髄移植後にサイトメガロウイルス網膜炎を発症した成人T細胞白血病
- 8p11関連の染色体異常を伴わない
- 当科における成人ALLに対する地固め療法としてのHyper-CVAD/High-dose MTX-Ara-C療法の治療成績
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Delayed Recovery of Normal Hematopoiesis in Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia: A Comparison to All-trans Retinoic Acid Treatment
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Maintenance and preemptive therapy with ganciclovir for cytomegalovirus colitis with extremely high antigenemia in adult T-cell leukemia
- Sperm cryopreservation in patients with hematologic malignancies
- Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand
- Leuprorelin Acetate for Female Patients with Newly Diagnosed Acute Leukemia Receiving Chemotherapy
- Retropharyngeal Abscess due to Methicillin-resistant Staphylococcus aureus in a Case of Acute Myeloid Leukemia
- Iron Deficiency Anemia with Marked Thrombocytosis Complicated by Central Retinal Vein Occlusion
- Involvement of the Esophagus and Stomach as a First Manifestation of Varicella Zoster Virus Infection after Allogeneic Bone Marrow Transplantation
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- How High Can We Increase Complete Remission Rate in Adult Acute Myeloid Leukemia?
- 4 Activity of the Science Council of Japan Aiming for Tobacco-free Society in Japan(The 6th Anti-Smoking Promotion Seminar, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Treatment of chronic myeloid leukemia with imatinib mesylate
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- AA amyloidosis associated with macroglobulinemia
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Guest editorial : Introducing progress in hematology in this issue
- Bone Marrow Metastasis of Malignant Melanoma